C 18 H 19 BrClNO 2 S 2 , monoclinic, P21/c (no. 14), a = 21.324(6) Å,
. 
Source of material

The mixture of N-(2-(4-chlorophenyl)pent-4-en-1-yl)-4-
methylbenzenesulfonamide, K 2 CO 3 , bis(triphenylphosphine) palladium(II) dichloride and N-bromosuccinimide was stirred for 1 h at room temperature to obtain the title compound with the yield of 94%. The solution of n-heptane and ethyl acetate was left to gradually volatilize in the atmosphere to obtain the single crystal.
Experimental details
The U iso values of the hydrogen atoms of methyl groups were set to 1.5 Ueq(C) and the U iso values of phenyl and methylene hydrogen atoms were set to 1.2 Ueq(C).
Discussion
The title compound is an important building block for the synthesis of bioactive molecules. The bromine atom can easily be replaced by other functional groups to generate corresponding products [1] [2] [3] [4] [5] [6] [7] . They have been widely used as broad-spectrum anti-bacterial agents [8] , these been reported in the utilize of anti-cancer research [9, 10] and also arouse a signi cant pharmacological interest [11] . In the title structure, the pyrrolidine ring adapts a twisted envelope conformation. The dihedral angle between the two phenyl ring systems is 87.68(3)°, and the dihedral angle between the mean plain of sulfonyl group (O1, S1 and O2) and its connected phenyl ring is 55.90(6)°, but the dihedral angle with the other phenyl ring is 37.69(3)°. No conventional hydrogen bonds were found.
